ecancer

Hypoxia related mRNA biomarker to predict biochemical failure and metastasis for prostate cancer

Dr Ananya Choudhury - The Christie NHS Foundation Trust, Manchester, UK

8 Feb 2018

Focus on screening, not biomarkers

Dr Hain Van Poppel - European Association of Urology, Arnhem, The Netherlands

14 Dec 2017

Effective implementation of personalised medicine guidelines

Prof James N'Dow - European Association of Urology (EAU), Arnhem, The Netherlands

11 Dec 2017

Editor's Choice for November 2017

Prof Gordon McVie - Founding Editor, ecancer

4 Dec 2017

Prostate cancer in sub-Saharan Africa

Dr Timothy Rebbeck - Dana-Farber Cancer Institute, Boston, USA

21 Nov 2017

Editor's Choice for September 2017

Prof Gordon McVie - Founding Editor, ecancer

27 Sep 2017

Bladder cancer's relationship with the urinary and gut microbiomes

Dr Jeremy Burton - Lawson Health Research Institute, London, Canada

21 Sep 2017

ESMO 2017 roundup with Dr Bishal Gyawali (1/2)

Dr Bishal Gyawali - Nagoya University, Nagoya, Japan

11 Sep 2017

Nivolumab and ipilimumab for metastatic kidney cancer

Dr Bernard Escudier - Institut Gustave Roussy, Villejuif, France

11 Sep 2017

RANGE: docetaxel with or without ramucirumab for metastatic urothelial carcinoma

Prof Daniel Petrylak - Yale Cancer Center, New Haven, Connecticut, USA

10 Sep 2017

RANGE trial of ramucirumab for urothelial cancer

Prof Daniel Petrylak - Yale Cancer Center, New Haven, Connecticut, USA

10 Sep 2017

Phase Ib/II trial of combination PD-1 therapy against kidney cancer

Dr Chung-Han Lee - Memorial Sloan Kettering Cancer Center, New York, USA

9 Sep 2017

More from ecancer